Back to Results
First PageMeta Content
Pharmacology / Dermatologic and Ophthalmic Drugs Advisory Committee / Center for Drug Evaluation and Research / Ranibizumab / Genentech / Macular degeneration / Macular edema / Intravitreal administration / Food and Drug Administration / Medicine / Pharmaceutical sciences


The committee will discuss saxagliptin tablets, by Bristol-Myers Squibb, for the treatment of hyperglycemia in adults with type 2 diabetes mellitus
Add to Reading List

Open Document

File Size: 49,46 KB

Share Result on Facebook

Company

AMD / ThromboGenics Inc. / Genentech Inc. / M.D. / /

Event

FDA Phase / /

Facility

Meeting FDA White Oak Campus / White Oak Conference Center / /

MedicalCondition

macular hole / diabetic macular edema / retinal vein occlusion / macular degeneration / Inc. Therapeutic Rationale Diabetic Macular Edema / /

Organization

Dermatologic and Ophthalmic Drugs Advisory Committee / Center for Drug Evaluation and Research / office of New Drugs / FOOD AND DRUG ADMINISTRATION / office of Antimicrobial Products / Ophthalmology Products / Ophthalmic Drugs Advisory Committee / /

Person

Hearing Rhea Lloyd / Michael X. Repka / Yvette Waples / /

Position

Federal Officer / Medical Officer / Deputy Director / Division of Transplant / /

Product

Ranibizumab injection / LUCENTIS / /

SocialTag